SGMO

Sangamo Therapeutics, Inc. Common Stock
Data: 2026-01-30
$0.5355
Price
-0.57%
Change
$1.4
52W High
$0.3552
52W Low

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Quick Stats
Jan 30, 2026

54.0

AI Score

HOLD

1.93

Volume Ratio

Mar 16, 2026

Next Earnings

14

+ve Days (30d)

16

-ve Days (30d)

SGMO Stock Summary

Last updated Jan 30, 2026

SGMO is currently trading at $0.5355, positioned below its 200-day moving average of $0.54, suggesting bearish momentum. The stock has a 52-week range of $0.3552 to $1.4.

Technical Analysis: The 50-day moving average stands at $0.44, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 66.634, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.119, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates SGMO at 54.0/100 with a HOLD recommendation.

SGMO (Sangamo Therapeutics, Inc. Common Stock) Indicators

Last updated Jan 30, 2026

Indicator Value
RSI(14) 66.634
CMF (20) 0.119
ROC (10) 24.535
ADX (14) 21.873
Indicator Value
MACD (12,26,9) -0.0
AROONOSC (14) 14.286
WILLAMS %R (14) -1.851
MFI (14) 57.85
SGMO Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

SGMO Price vs Max Options Open Interest
SGMO Max Change In Options Open Interest

SGMO Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SGMO Daily Out of Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SGMO Daily In the Money Options - Sort by Max open Interest (near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

SGMO Most Active Options by Volume(near term)

31st January 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Sangamo Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.

SGMO Moving Averages Analysis

Sangamo Therapeutics, Inc. Common Stock has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jan 30, 2026

SGMO (Sangamo Therapeutics, Inc. Common Stock) Simple Moving Averages

Moving Averages are last updated Jan 30, 2026

Days MA
10 0.41
20 0.43
30 0.43
50 0.44
100 0.51
200 0.54

SGMO Fundamental Analysis

P/E (Forward) 0
P/E (Trailing) --
Market Cap ($) 122.5 million
Earnings/Share ($) -0.45
Net Proft Margin (%) 0
Dividend/Share ($) --
EPS Estimate Current Year ($) -0.41
EPS Estimate Next Year ($) -0.23
WallStreet Target Price ($) 3.8125
Most Recent Quarter